Vietnam · Delayed Price · Currency is VND HNX:MED Statistics
Total Valuation
HNX:MED has a market cap or net worth of VND 228.34 billion. The enterprise value is 231.16 billion.
| Market Cap | 228.34B |
| Enterprise Value | 231.16B |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
HNX:MED has 12.41 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 12.41M |
| Shares Outstanding | 12.41M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 59.02% |
| Owned by Institutions (%) | n/a |
| Float | 5.09M |
Valuation Ratios
The trailing PE ratio is 9.51.
| PE Ratio | 9.51 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | 17.37 |
| P/OCF Ratio | 12.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.60, with an EV/FCF ratio of 17.58.
| EV / Earnings | 9.63 |
| EV / Sales | 0.79 |
| EV / EBITDA | 15.60 |
| EV / EBIT | 28.99 |
| EV / FCF | 17.58 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.59 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 3.26 |
| Debt / FCF | 3.68 |
| Interest Coverage | 4.19 |
Financial Efficiency
Return on equity (ROE) is 7.27% and return on invested capital (ROIC) is 1.90%.
| Return on Equity (ROE) | 7.27% |
| Return on Assets (ROA) | 1.05% |
| Return on Invested Capital (ROIC) | 1.90% |
| Return on Capital Employed (ROCE) | 2.34% |
| Weighted Average Cost of Capital (WACC) | 3.96% |
| Revenue Per Employee | 940.00M |
| Profits Per Employee | 77.45M |
| Employee Count | 310 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, HNX:MED has paid 4.21 billion in taxes.
| Income Tax | 4.21B |
| Effective Tax Rate | 14.92% |
Stock Price Statistics
The stock price has decreased by -32.60% in the last 52 weeks. The beta is -0.03, so HNX:MED's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -32.60% |
| 50-Day Moving Average | 24,050.00 |
| 200-Day Moving Average | 24,480.00 |
| Relative Strength Index (RSI) | 30.35 |
| Average Volume (20 Days) | 2,608 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HNX:MED had revenue of VND 291.40 billion and earned 24.01 billion in profits. Earnings per share was 1,934.54.
| Revenue | 291.40B |
| Gross Profit | 67.79B |
| Operating Income | 7.98B |
| Pretax Income | 28.22B |
| Net Income | 24.01B |
| EBITDA | 14.82B |
| EBIT | 7.98B |
| Earnings Per Share (EPS) | 1,934.54 |
Balance Sheet
The company has 31.29 billion in cash and 48.37 billion in debt, with a net cash position of -17.08 billion or -1,376.28 per share.
| Cash & Cash Equivalents | 31.29B |
| Total Debt | 48.37B |
| Net Cash | -17.08B |
| Net Cash Per Share | -1,376.28 |
| Equity (Book Value) | 340.21B |
| Book Value Per Share | 27,414.10 |
| Working Capital | 72.35B |
Cash Flow
In the last 12 months, operating cash flow was 18.11 billion and capital expenditures -4.96 billion, giving a free cash flow of 13.15 billion.
| Operating Cash Flow | 18.11B |
| Capital Expenditures | -4.96B |
| Depreciation & Amortization | 6.84B |
| Net Borrowing | 3.94B |
| Free Cash Flow | 13.15B |
| FCF Per Share | 1,059.30 |
Margins
Gross margin is 23.26%, with operating and profit margins of 2.74% and 8.24%.
| Gross Margin | 23.26% |
| Operating Margin | 2.74% |
| Pretax Margin | 9.68% |
| Profit Margin | 8.24% |
| EBITDA Margin | 5.09% |
| EBIT Margin | 2.74% |
| FCF Margin | 4.51% |
Dividends & Yields
This stock pays an annual dividend of 1,200.00, which amounts to a dividend yield of 6.52%.
| Dividend Per Share | 1,200.00 |
| Dividend Yield | 6.52% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 62.46% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 6.50% |
| Earnings Yield | 10.52% |
| FCF Yield | 5.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HNX:MED has an Altman Z-Score of 2.56 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.56 |
| Piotroski F-Score | 4 |